Lv3
340 积分 2024-03-07 加入
Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response
1个月前
已完结
Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancer
1个月前
已完结
Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancer
1个月前
已完结
The frontier of neoadjuvant therapy in non-small cell lung cancer beyond PD-(L)1 agents
1个月前
已完结
Analysis of Oligomeric and Glycosylated Proteins by Size-Exclusion Chromatography Coupled with Multiangle Light Scattering
1个月前
已完结
重组生物技术产品连续制造中病毒安全控制的一般考量
3个月前
已完结
ADCC enhancement: A conundrum or a boon to mAb therapy?
6个月前
已完结
From Efficiency to Yield: Exploring Recent Advances in CHO Cell Line Development for Monoclonal Antibodies
6个月前
已完结
Lyophilization Cycle Development for a High-Concentration Monoclonal Antibody Formulation Lacking a Crystalline Bulking Agent
8个月前
已完结
皖公网安备34019202002308
